Under the leadership of Chairman and Founder Tim Keller, U.S. Diabetes Care (USDC) has launched an education program aimed at reversing prediabetes, Type 2 diabetes, type 3 diabetes, gestational diabetes, and insulin resistance through evidence-based education, expert support, and practical, long-term lifestyle strategies. This initiative represents a significant shift in the company’s mission to transform diabetes management.
The new program is a self-paced program built on expert-created resources, including nutrition education, movement strategies, and
shifts, designed to empower individuals to make sustainable lifestyle changes. The program targets individuals with diabetes, leveraging emerging research proven at a clinic in Morristown, Tenn, suggesting that the condition can be reversed or significantly improved, their health outcomes and reduce dependency on medications through sustained lifestyle changes and precise glucose monitoring.
“Reversing Type 2 diabetes is not just a possibility—it’s a reality we’re working to make accessible,” said Keller, whose company has been involved in diabetes technology since the founding of its clinic in 2010.
The education program is grounded in clinical evidence showing that significant weight loss, improved diet, and physical activity can restore insulin sensitivity in many patients with diabetes, potentially reducing or eliminating the need for medication. The USDC program offers interactive tools, including meal planning, exercise tracking, and real-time glucose monitoring, to support users in making sustainable lifestyle changes. The company has partnered with endocrinologists, dietitians, and fitness experts to deliver a holistic approach, showing promising results: over 90 percent of those who complete the program show measurable improvements—and many reverse their condition entirely.
Keller’s vision comes at a critical juncture, as the Centers for Disease Control and Prevention reports that over 38 million Americans live with diabetes, the majority with Type 2. The economic burden of the disease, estimated at $412.9 billion annually in the U.S., underscores the urgency of scalable solutions. Unlike traditional diabetes management, which focuses on controlling symptoms, U.S. Diabetes Care’s approach emphasizes prevention and reversal, aligning with growing public interest in proactive health strategies.
The company faces challenges, including skepticism from some medical professionals about the feasibility of widespread diabetes reversal and competition from larger firms like Dexcom and Medtronic. However, Keller remains undeterred, pointing to the program’s early successes and the affordability of U.S. Diabetes Care’s devices as key differentiators. The education program also focuses on restoring long-term health by teaching participants how to identify and address the root causes of diabetes in their daily lives.
As U.S. Diabetes Care rolls out this program nationwide in 2026, Keller says he seeks to redefine the fight against diabetes. “Our mission is to give people hope and the tools to reclaim their health,” he said. With its blend of technology and human-centered care, U.S. Diabetes Care is poised to lead a paradigm shift in diabetes treatment.
For more information, visit www.usdiabetescare.com.
